HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuji Murakami Selected Research

nedaplatin

1/2018Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.
5/2017Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancer.
12/2015Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.
9/2014Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy.
2/2013Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
4/2012Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
1/2012Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
1/2011Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuji Murakami Research Topics

Disease

35Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2010
15Neoplasms (Cancer)
03/2022 - 08/2012
7Disease Progression
01/2022 - 05/2009
6Lung Neoplasms (Lung Cancer)
04/2022 - 01/2010
6Pneumonia (Pneumonitis)
01/2022 - 02/2010
4Tuberculosis (Tuberculoses)
06/2021 - 07/2007
4Neoplasm Metastasis (Metastasis)
01/2020 - 11/2017
4Carcinoma (Carcinomatosis)
10/2017 - 01/2011
3Fatigue
12/2019 - 02/2010
3Body Weight (Weight, Body)
12/2018 - 03/2007
3Neutropenia
05/2017 - 02/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2015 - 01/2011
2Diarrhea
01/2022 - 02/2013
2Adenocarcinoma
11/2016 - 01/2010
2Febrile Neutropenia
03/2013 - 02/2013
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2013 - 01/2012
2Rheumatoid Arthritis
03/2009 - 02/2007
1Microsatellite Instability
03/2022
1Colitis
01/2022
1Dermatitis
01/2022
1Exanthema (Rash)
01/2022
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
12/2021
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2020
1Chest Pain (Chest Pains)
12/2019
1Cough
12/2019
1Vision Disorders (Hemeralopia)
07/2019
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2019
1Autoimmune Diseases of the Nervous System
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Thrombocytopenia (Thrombopenia)
05/2017
1Thymoma (Thymic Carcinoma)
07/2016
1Lymphatic Metastasis
06/2015
1Vomiting
02/2013
1Hyponatremia
02/2013
1Hypotension (Low Blood Pressure)
02/2013

Drug/Important Bio-Agent (IBA)

10Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 02/2010
8durvalumabIBA
01/2022 - 11/2017
8nedaplatinIBA
01/2018 - 01/2011
5Cisplatin (Platino)FDA LinkGeneric
04/2022 - 01/2010
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2010
5NivolumabIBA
12/2021 - 01/2019
4Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2018
4Immune Checkpoint InhibitorsIBA
03/2022 - 03/2020
4B7-H1 AntigenIBA
01/2021 - 11/2017
42- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2017 - 02/2010
3EnzymesIBA
04/2022 - 05/2008
3Interferon-gamma (Interferon, gamma)IBA
03/2022 - 05/2008
3LigandsIBA
03/2022 - 10/2019
3Tyrosine Kinase InhibitorsIBA
02/2022 - 01/2019
3pembrolizumabIBA
06/2021 - 12/2020
3PlatinumIBA
01/2021 - 11/2017
2Pemetrexed (MTA)FDA Link
01/2021 - 12/2019
2AntibodiesIBA
12/2020 - 01/2013
2Bevacizumab (Avastin)FDA Link
12/2019 - 01/2013
2Alanine Transaminase (SGPT)IBA
07/2019 - 02/2010
2Docetaxel (Taxotere)FDA Link
01/2019 - 05/2017
2DNA (Deoxyribonucleic Acid)IBA
10/2017 - 08/2014
2ParaffinIBA
10/2017 - 08/2014
2Formaldehyde (Formol)FDA Link
10/2017 - 08/2014
2Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 02/2010
2Gefitinib (Iressa)FDA Link
01/2012 - 02/2010
2Heme Oxygenase-1IBA
01/2010 - 08/2008
2AntigensIBA
05/2009 - 03/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2009 - 02/2009
2Tuberculin (PPD)IBA
03/2009 - 07/2007
1Cytochrome P-450 CYP3AIBA
04/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2022
1Aprepitant (Emend)FDA Link
04/2022
1AntiemeticsIBA
04/2022
1Interleukin-8 (Interleukin 8)IBA
03/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2022
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020
1CrizotinibIBA
07/2019
1Aspartic Acid (Aspartate)FDA Link
07/2019
1osimertinibIBA
01/2019
1RamucirumabIBA
01/2019
1AutoantibodiesIBA
01/2019
1Androgen Receptors (Androgen Receptor)IBA
07/2016
1Keratin-19 (Keratin 19)IBA
06/2015
1Carcinoembryonic AntigenIBA
06/2015
1Peptides (Polypeptides)IBA
09/2014
1Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
09/2014
1CreatinineIBA
03/2013
1TegafurIBA
03/2013
1amrubicinIBA
03/2013
1UracilIBA
03/2013

Therapy/Procedure

15Drug Therapy (Chemotherapy)
01/2021 - 01/2010
14Therapeutics
01/2022 - 07/2007
6Chemoradiotherapy
01/2022 - 11/2017
4Combination Drug Therapy (Combination Chemotherapy)
01/2013 - 02/2010
2Aftercare (After-Treatment)
06/2021 - 01/2012
2Adjuvant Chemotherapy
01/2018 - 11/2016
2Radiotherapy
11/2017 - 05/2017
2Operative Surgical Procedures
11/2016 - 08/2012
1Immunotherapy
12/2020
1Molecular Targeted Therapy
10/2017
1Thyroidectomy
07/2016
1Lymph Node Excision (Lymph Node Dissection)
06/2015
1Segmental Mastectomy (Lumpectomy)
06/2015